Dimerix Receives FDA feedback for DMX-200 trial
Dimerix (DXB) moves a step closer towards phase three clinical trials for its DMX-200 candidate following a...
Dimerix (DXB) has awarded $1M from the Medical Research Future Fund (MRFF) Biomedical Translation Bridge (BTB) program
Dimerix will use the funding to...